Business

BioBridges Promotes Jenny Thayer to Chief Strategy Officer

BioBridges, a leading provider of clinical and strategic solutions for the life sciences industry, proudly announces the promotion of Jenny Thayer (MBA, Ed.M., MA) to Chief Strategy Officer (CSO).

In this newly formed executive role, Thayer will lead the organization’s strategic planning and communications, ensuring alignment across departments to drive growth, innovation, and long-term success.

With more than 25 years’ experience in biotech and pharmaceutical companies, spanning both small startups and global enterprises, Thayer is well suited to help BioBridges expand into new markets while keeping the company true to the qualities that contributed to its early success.

“Jenny has a unique ability to connect strategic vision with operational execution,” says Mark Bouck, Chairman and CEO of BioBridges. “She brings not only deep industry knowledge, but also a passion for supporting others in achieving their best potential. Her leadership will be a driving force behind our next chapter of growth.”

Thayer has been a key leader at BioBridges for more than 12 years. She began her career in regulatory affairs and steadily advanced into leadership roles, guiding teams through mergers, acquisitions, and reorganizations while building new functions from the ground up.

Known for her expertise in navigating complexity and fostering high-performance teams, Thayer has successfully led initiatives including major marketing submissions and large-scale platform rollouts.

As CSO, Thayer will collaborate across all levels of the organization to develop, track, and measure BioBridges’ corporate strategy and communications. Her primary focus areas include strategy, communications, product development, mergers and acquisitions, and functional expertise.

In her previous advisory role at BioBridges, Thayer worked closely with both clients and consultants to align expertise with organizational needs, ensuring successful outcomes for all stakeholders. She remains enthusiastic about applying efficient and effective practices to help others thrive in dynamic, high-stakes environments.

About BioBridges

BioBridges delivers flexible solutions for life sciences companies from discovery through commercialization. Our global reach of expertise, services, and technologies empowers our clients to bring innovative solutions to the patients who need them.

For Media Inquiries, contact:

Stacey Ackerman, Head of Marketing
sackerman@biobridges.com
(651) 285-3524

Joseph Wilson

Joseph Wilson is a veteran journalist with a keen interest in covering the dynamic worlds of technology, business, and entrepreneurship.

Recent Posts

New Research Peptide “Pepe-132” Inspired by Ancient New Zealand Frog Demonstrates Promising Anti-Aging Potential in Preclinical Studies

Boston, MA – April 25, 2026 – Apex BioTherapeutics today announced the successful development and…

7 hours ago

Human Garage signs 12-show deal with Spark TV to bring self-healing content to mainstream audiences

Partnership with streaming platform marks the movement's entry into long-form wellness entertainment Miami, Fla. —…

1 day ago

Dogecoin Cash, Inc. (OTCQB: DOGP) Publishes Dogecoin Gold White Paper Detailing Digital Asset Framework

MESQUITE, NV — Dogecoin Cash, Inc. (OTCQB: DOGP) (“DOGP” or the “Company”) today announced the…

1 day ago

Berkeley Executive Coaching Institute Earns ICF Level 1 Accreditation for Executive Coaching Certification Program

Accreditation provides BECI graduates a streamlined path to the ICF Associate Certified Coach (ACC) credential,…

1 day ago

Press Release: Memcyco Wins Gold in 2026 Global InfoSec Awards for Best Solution – Account Takeover Protection

San Francisco, California – Memcyco, a leader in real-time digital impersonation and account takeover (ATO)…

1 day ago

CloudBooster Launches Change Control Plane Pilot for AWS Teams

Prague-based company opens applications for early access to its governed lifecycle platform for infrastructure changes…

1 day ago

This website uses cookies.